Correlation of baseline 18F-FDG-PET/CT parameters with the outcome of advanced melanoma patients treated with the pd-1 blocking monoclonal antibody pembrolizumab

Research output: Unpublished contribution to conferenceUnpublished abstract

Participation in workshop, seminar

Search results

  • ORC day 2018

    Marleen Keyaerts (Participant)

    18 Oct 2018

    Activity: Participating in or organising an eventParticipation in workshop, seminar